Skip to main content

Cabozantinib Alternatives Compared

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Cabozantinib Lutathera (lutetium lu 177 dotatate) Lanreotide
View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Cabozantinib Lutathera (lutetium lu 177 dotatate) Lanreotide
Prescription only

Prescribed for Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Cancer, Neuroendocrine Tumors. Cabozantinib may also be used for purposes not listed in this medication guide.

Prescription only

Prescribed for Neuroendocrine Tumors. Lutathera may also be used for purposes not listed in this medication guide.

Prescription only

Prescribed for Neuroendocrine Tumors, Carcinoid Syndrome, Acromegaly. Lanreotide may also be used for purposes not listed in this medication guide.

More about Cabozantinib More about Lutathera (lutetium lu 177 dotatate) More about Lanreotide
Ratings & Reviews

Cabozantinib has an average rating of 6.6 out of 10 from a total of 27 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 22% reported a negative effect.

Be the first to share your experience with this drug.

Lanreotide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect.

View all 27 reviews

Review this drug

View all 1 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

View all Cabozantinib side effects

View all Lutathera side effects

View all Lanreotide side effects
Drug Class
Generic Availability

N/A

No lower cost generic approved

Lower cost generic
Pricing and Coupons * Prices are without insurance

We could not find an exact match for this medicine. Try searching the Price Guide directly.
Quantity 1 solution
Strength 370 MBq/mL
Per unit* $63,857.00
Cost* $63,857.00

View all Lutathera prices

Quantity 0.5 mL
Strength 120 mg/0.5 mL
Per unit* $5,308.44 - $14,959.66
Cost* $2,654.22 - $7,479.83

View all Lanreotide prices

Get free Discount Card

Get free Discount Card

Get free Discount Card

Dosage Forms

N/A
  • Intravenous solution
  • Subcutaneous solution
Brand Names
Cabometyx, Cometriq

N/A

 Somatuline Depot
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

99 hours

71 hours

720 hours
CSA Schedule 1 View glossary of CSA terms
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
Pregnancy Category
D
Category D Positive evidence of risk

See the full pregnancy warnings document.

Summary unavailable.

See the full pregnancy warnings document.
C
Category C Risk cannot be ruled out

See the full pregnancy warnings document.
Drug Interactions

A total of 531 drugs are known to interact with Cabozantinib:

  • 322 major drug interactions (1075 brand and generic names)
  • 206 moderate drug interactions (768 brand and generic names)
  • 3 minor drug interactions (6 brand and generic names)

A total of 236 drugs are known to interact with Lutathera:

  • 82 major drug interactions (307 brand and generic names)
  • 154 moderate drug interactions (464 brand and generic names)

A total of 163 drugs are known to interact with Lanreotide:

  • 4 major drug interactions (8 brand and generic names)
  • 147 moderate drug interactions (482 brand and generic names)
  • 12 minor drug interactions (24 brand and generic names)
Alcohol/Food/Lifestyle Interactions
  • Cabozantinib should be taken on an empty stomach, one hour before or two hours after a meal. Do... View more

No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
  • Lanreotide may affect the absorption of dietary nutrients and medications that you take by mouth... View more
Disease Interactions
First Approval Date

November 29, 2012

N/A

N/A
WADA Class View classifications

N/A

N/A

N/A
More Information
Patient Resources
Professional Resources
Related Treatment Guide

1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Compare Drugs

To view a report comparing 3 (or more) medications, please sign in or create an account.

Create an account Sign In